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Pretrial Drug Testing-An Essential Component 
of the National Drug Control Strategy 
Reggie B. Walton* 
Gary J. Peters** 
J. Anthony Towns*** 
When President George Bush unveiled the first National 
Drug Control Strategy in September 1989, he emphasized that 
combatting drug abuse and drug trafficking was the number 
one priority on his domestic affairs agenda. 1 The President's 
emphasis on this tragic and terribly destructive problem was 
consistent with its importance in the public's mind, as reflected 
in numerous polls and surveys. The President has continually 
reiterated the importance he attaches to the Nation's counter-
drug efforts, and while opinion polls may now show other 
problems to be paramount in the public's mind, the drug 
problem remains a vital concern.2 
* Reggie B. Walton received his Juris Doctorate from the American 
University, Washington College of Law. He served as Associate Judge and Deputy 
Presiding Judge of the Criminal Division of the Superior Court of the District of 
Columbia. In 1989, he was appointed by President Bush to be the Associate 
Director of the Office of National Drug Control Policy, where he headed the 
Bureau of State and Local Affairs. In May of 1991, he was appointed as Senior 
White House Advisor for Crime. He served in that position until December of 1991, 
when he returned to the Superior Court where he now serves as an Associate 
Judge. 
** Gary J. Peters received his Juris Doctorate, from the University of 
Michigan Law School and is the Bureau of State and Local Affair's Special 
Assistant for Law Enforcement and Criminal Justice. 
*** J. Anthony Towns received his Juris Doctorate from Georgetown University 
Law Center and is currently Judge Walton's law clerk. 
1. In his Inaugural Address (January 20, 1989), President Bush said, "There 
are few clear areas in which we as a society must rise up united and express our 
intolerance. The most obvious now is drugs. And when that first cocaine was 
smuggled in on a ship, it may as well have been a deadly bacteria, so much has it 
hurt the body, the soul of our country. And there is much to be done and to be 
said, but take my word for it: This scourge will stop!" 1 PUB. PAPERS 3 (1989). 
2. See, e.g., The New York Times/CBS News Poll, N.Y. TIMES, Sept. 6, 1990, 
at A22. 
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This article addresses only one of the many weapons the 
United States has and needs in its arsenal to effectively combat 
the scourge of drugs: the expanded use of drug testing in the 
criminal justice system, and in particular, testing during the 
pretrial stage of the process. Such drug testing through 
urinalysis has been encouraged in each of the National Drug 
Control Strategies issued to date. This position is consistent 
with other themes incorporated in those Strategies and with 
the Constitutional protections provided by the Fourth, Fifth, 
and Sixth Amendments.3 As such, the use of drug testing as a 
part of the criminal justice system should be further expanded 
at the Federal, State and local levels. While this article 
confines itself primarily to the limited arena of pretrial drug 
testing, it should be noted that the Bush Administration has 
also encouraged the use of drug testing throughout the criminal 
justice process and also in the workplace, in both the public 
and private sectors.4 
I. THE NATIONAL DRUG CONTROL STRATEGY'S EMPHASIS ON 
DRUG TESTING IN THE CRIMINAL JUSTICE SYSTEM 
The third edition of the National Drug Control Strategy, 
prepared by the Office of National Drug Control Policy 
(ONDCP) was issued by President Bush on January 31, 1991. 
Like its predecessors, the Strategy presents a comprehensive 
approach to controlling both the supply of illicit drugs and the 
demand for them. The Strategy sets policies and encourages 
measures designed to implement those policies in each of seven 
priority subject areas: (1) the Criminal Justice System; (2) 
Drug Treatment; (3) Education, Community Action, and the 
Workplace; (4) International Initiatives; (5) Interdiction Efforts; 
( 6) Research; and (7) Intelligence. 
Certain themes are consistently emphasized throughout 
these different priority subject areas, including that of 
accountability. For too long in this country, both drug offenders 
and many of the programs designed to apprehend, prosecute, 
punish or treat them have been able to avoid accountability. To 
3. See discussion infra part III. 
4. THE WHITE HOUSE, NATIONAL DRUG CONTROL STRATEGY, 70-73, 149 (1991) 
(hereinafter NATIONAL DRUG CONTROL STRATEGY Ill); OFFICE OF NATIONAL DRUG 
CONTROL POLICY, STATE DRUG CONTROL STATUS REPORT (WHITE PAPER) 17-18 
(1990) (hereinafter STATUS REPORT); OFFICE OF NATIONAL DRUG CONTROL POLICY, 
BUILDING A DRUG-FREE WORKPLACE (GUIDE FOR STATE LEGISLATION) (1990). 
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address this deficiency, the Strategy has encouraged, among 
other measures: new and different kinds of accountability, so 
that all drug offenders, casual and occasional users as well as 
dealers, can be held responsible for their aberrant behavior; 
evaluations of the effectiveness of anti-drug programs (whether 
oriented towards law enforcement, prevention, treatment, or 
corrections) receiving Federal grant dollars; and the expanded 
use of quantified and scheduled objectives to better assess 
longitudinal program effectiveness. 
There are a number of specific policies and programs 
encouraged in the National Drug Control Strategy that reflect 
this principle of accountability. One such policy that the Bush 
Administration has promoted from its inception has been the 
expanded use of drug testing in the criminal justice system. 
The initial Strategy, issued by President Bush on September 5, 
1989, called for drug testing at every stage of the criminal 
justice process.5 A few months later, on January 25, 1990, 
President Bush's Second National Drug Control Strategy was 
issued. It, too, called for drug testing through urinalysis within 
the criminal justice system for those on pretrial and post-
conviction release.6 Like its predecessors, the Third Strategy 
calls for the use of drug testing through urinalysis at all stages 
of the criminal justice process, from the time of arrest through 
parole. 7 
Following publication of the initial Strategy, the 
Administration proposed legislation that would have 
conditioned receipt of Federal criminal justice funds upon 
States adopting drug testing programs for targeted classes of 
individuals throughout their criminal justice systems.8 While 
Congress has not yet enacted the legislation, the 
Administration continues to support this requirement and will 
pursue its enactment.9 
5. THE WHITE HOUSE, NATIONAL DRUG CONTROL STRATEGY 26, 100 (1989) 
[hereinafter NATIONAL DRUG CONTROL STRATEGY I]. 
6. THE WHITE HOUSE, NATIONAL DRUG CONTROL STRATEGY 25-26 (1990) 
[hereinafter NATIONAL DRUG CONTROL STRATEGY II]. The President submits a new 
National Drug Control Strategy to Congress by February 1 of each year, as 
required by Section 1005 of the Anti-Drug Abuse Act of 1988, Public L. No. 100-
690, 102 Stat. 4181 (codified at 21 U.S.C. §§ 1502, 1504 (1988)). To date, each 
volume of the Strategy has reaffirmed-and then built upon-the policies set forth 
in the initial Strategy. See NATIONAL DRUG CONTROL STRATEGY II, supra, at 6; 
NATIONAL DRUG CONTROL STRATEGY III, supra note 4, at 2-3. 
7. NATIONAL DRUG CONTROL STRATEGY III, supra note 4, at 34. 
8. S. 1711, lOlst Cong., 1st Sess. (1989). 
9. NATIONAL DRUG CONTROL STRATEGY III, supra note 4, at 34. On March 11, 
344 B.Y.U. JOURNAL OF PUBLIC LAW [Volume 5 
Drug testing programs can improve counter-drug efforts, 
and the accountability of those efforts, in a number of 
overlapping areas. For example, they serve as an "early 
warning system" that provides another method of monitoring 
pretrial and post-conviction releasees. Those who violate the 
conditions of their release by continued drug use can be 
detected quickly and sanctioned. Test results can also help 
judges allocate scarce treatment slots to those who need them 
most. Moreover, such testing programs, accompanied by swift 
and certain penalties for continued drug use in violation of a 
condition of community release, can provide an incentive for 
criminal defendants to get off, and stay off, illegal drugs. 
II. DRUG USE AND ITS RELATIONSHIP TO CRIME AND FAILURE 
TO APPEAR FOR FUTURE COURT PROCEEDINGS 
A. Drug Use and Crime 
The government has a legitimate interest both in prevent-
ing crime and in securing the appearance of charged offenders 
at future court proceedings. 10 In turn, the legitimacy of re-
quired urinalysis programs, at least at the pretrial stage, de-
pends on whether the procedure is reasonably related to fur-
thering those interests. u There is substantial evidence of such 
a relationship. 
In 1986, a panel of criminal justice professionals convened 
by the National Research Council of the National Academy of 
Sciences concluded that while the connection may be a complex 
one, "[t]he relationship between substance abuse and criminal 
activity is widely thought to be firmly established, supported by 
empirical research as well as informal observations of criminal 
justice operations."12 A 1986 United States Department of 
Justice survey of State prison inmates showed that one in three 
offenders was under the influence of some drug when they 
committed the offense for which they had been charged. For 
1991, the Administration's drug testing proposal for criminal justice systems was 
submitted as part of the Comprehensive Violent Crime Control Act of 1991, S. 635, 
102d Cong., 1st Sess. §§ 901-902. 
10. Richard B. Abell, Pretrial Drug Testing: Expanding Rights and Protecting 
Public Safety, 57 GEO. WASH. L. REV. 943, 945, 950 (1989). 
11. ld. 
12. PANEL ON RESEARCH ON CRIMINAL CAREERS, NATIONAL ACADEMY OF SC!ENC· 
ES 50 (A. Blumstein et al. eds., 1986). While serving as an Associate Judge on the 
District of Columbia's Superior Court, one of the co-authors of this article, Reggie 
B. Walton, was a member of this Panel. 
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certain offenses, the rates were even higher. 13 Numerous oth-
er studies conducted over the last decade have shown that drug 
involved offenders commit crimes with much greater frequency 
than offenders who are not drug users. 14 These crimes include 
not only continued drug violations and property-related offens-
es, but violent crimes as well. This is illustrated by the toxicol-
ogy data of the victims and the urinalysis test results of the 
assailants involved in the 435 homicides which occurred in the 
District of Columbia from January 1 to November 30, 1990, 
which indicated that most of the victims and the assailants had 
drugs in their systems at the time of their deaths or arrests. 15 
The Drug Use Forecasting (DUF) System, established by 
the National Institute of Justice, reveals that drug use is far 
more prevalent among arrestees, as compared to the non-ar-
restee population. Since 1986, the DUF program has used ran-
dom and voluntary urinalyses to test a sample of arrestees in 
selected major cities to determine recent drug use. By 1990, 
twenty-three cities had entered the DUF program, in which 
arrestees' urine samples are tested for the presence of ten dif-
ferent drugs (including cocaine, marijuana, phencyclidine-PCP, 
methamphetamine, heroin, and opium), and a report of the 
findings is released each quarter. 16 Admittedly, the DUF data 
does not reveal whether the user's need for drugs was a motive 
for the commission of the offense charged, or whether the ar-
restee was a chronic or an occasional userY Nevertheless, it 
is significant that the DUF program determines drug use pri-
13. BUREAU OF JUSI'ICE STATISTICS, U.S. DEP'r OF JUSTICE, STATE PRISON 
INMATE SURVEY, 1986: DRUG USE AND CRIME 3-4 (1988). 
14. See Christy A. Visher, Using Drug Testing to Identify High-Risk Defendants 
on Release: A Study in the District of Columbia, 18 J. CRIM. JUST. 321 (1990); see 
also MARY G. GRAHAM, U.S. DEP'T OF JU&'TICE, CONTROLLING DRUG ABUSE AND 
CRIME: A RESEARCH UPDATE (1987); BERNARD A. GROPPER, U.S. DEP'T OF JUSI'ICE, 
PROBING THE LINKS BETWEEN DRUGS AND CRIME (1985); James Q. Wilson, Drugs 
and Crime, in 13 DRUGS AND CRIME 521, 522 (Michael Tonry & Norval Morris 
eds., 1990) James K. Stewart, Quid Pro Quo: Stay Drug-Free and Stay on Release, 
57 GEO. WASH. L. REV. 68, 69 (1988). 
15. STATISTICAL ANALYSIS CENTER, OFFICE OF CRIMINAL JUSTICE PLANS AND 
ANALYSIS, DISTRICT OF COLUMBIA, DRUG ABUSE INDICATORS TREND REPORT FOR THE 
DISTRICT OF COLUMBIA (1991); see also Jan M. Chaiken & Marcia R. Chaiken, 
Drugs and Predatory Crime, in 13 DRUGS AND CRIME 203, 205, 212-13 (Michael 
Tonry & Norval Morris eds., 1990); Stewart, supra note 14, at 69. 
16. See, e.g., NATIONAL INST. OF JUSTICE, U.S. DEP'T OF JUSI'ICE, ARRESI'EE 
DRUG USE, JANUARY TO MARCH 1990 (1990). 
17. Eric D. Wish & Bernard A. Gropper, Drug Testing by the Criminal Justice 
System: Methods, Research, and Applications, in 13 DRUGS AND CRIME 321, 369 
(Michael Tonry & Norval Morris eds., 1990). 
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marily through urinalysis, which has proven to be a far more 
reliable method than self-reporting. 18 Moreover, the DUF pro-
gram focuses on drug use among those charged with crimes, a 
population that is underrepresented in other drug use surveys, 
such as the National Institute on Drug Abuse's National 
Household Survey. By using urinalysis to test a sample of those 
arrested in major cities, the DUF program provides concrete 
information about a subsection of the population where drug 
use is heavily concentrated. Indeed, the results of the DUF 
program to date reveal that the rate of drug use is as much as 
ten times greater among those arrested for serious crimes, as 
compared to those in the general population. 19 
B. Drug Use and Failure to Appear 
At least one judge who has previously written about pretri-
al drug testing has noted that assuring defendants' appearanc-
es at future court proceedings is a compelling govemmental 
concem.2° Clearly, this position is correct. When defendants 
fail to reappear for court proceedings, the criminal justice pro-
cess, under most circumstances, cannot go forward. This causes 
substantial inconvenience to not only the court and the attor-
neys, but perhaps more importantly, to the victims of crime. In 
addition, public funds are lost every time a case has to be ex-
tended to apprehend defendants who fail to come to court. 
It has been shown that drug use also has a negative effect 
on the reappearance rate of arrestees. In the District of Colum-
bia, for example, researchers found, after screening for other 
factors that might affect pretrial release risk such as back-
ground characteristics and prior record, that defendants iden-
tified through urine tests as recent drug users pose higher 
pretrial release risks than nonusers, both for failure to appear 
18. During an eight-month (June 1984-Jan. 1985) study of arrestees in the 
District of Columbia, less than one-half of the drug users identified by urine tests 
told researchers they were drug users. MARY A. TOBORG ET AL., U.S. DEP'T OF 
JUSTICE, ASSESSMENT OF PRETRIAL URINE TESTING IN THE DISTRICT OF COLUMBIA 5 
(1989). Similar results were obtained from a comparative study of urinalysis and 
self-reporting involving arrestees in New York City. Eric D. Wish & Bruce D. 
Johnson, The Impact of Substance Abuse on Criminal Careers, in 2 CRIMINAL CA-
REERS AND "CAREER CRIMINALS" 70 (Alfred Blumstien et al. eds., 1986). 
19. OFFICE OF NATIONAL DRUG CONTROL POLICY, LEADING DRUG INDICATORS 
(WHITE PAPER) 16-19 (1990). 
20. JUDGE ROBERT L. EVANS, RECORDER'S COURT FOR THE CITY OF D~<,'TROIT, 
DRUG TESTING WITHIN THE CRIMINAL JUSTICE SYSTEM: Is IT CONSTITUTIONAL? 
(MONOGRAPH) 12 (1988). 
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and pretrial rearrest.:l 1 A study of 2,606 New York City 
arrestees reached similar conclusions regarding the utility of 
urine test results in improving pretrial risk classification.22 It 
found that positive drug results were "significantly associated" 
with both failure to appear and the probability of rearrest. 23 
The New York City study also corroborated findings from 
the District of Columbia program that the use of specific drugs 
and the use of a combination of drugs relate in different ways 
to the risks of pretrial arrest, failure to appear, or overall pre-
trial misconduct (a composite measure used by the researchers, 
consisting of failure to appear, pretrial rearrest, or both). Those 
who tested positive for cocaine and/or heroin were found to be 
more likely to fail to appear, while those testing positive for 
PCP or a combination of three or more drugs were more likely 
to be arrested during the pretrial period.24 A third study con-
ducted by the National Institute of Justice, using data from 
New York and Washington, also concluded that defendants 
with positive drug tests at the time of their arrest, especially 
for several drugs, are more likely to be rearrested before trial 
and more likely to fail to appear than arrestees with similar 
profiles whose urine tests were negative.25 
Moreover, defendants who "participated" in Washington's 
pretrial urine-testing program-arrestees tested on four or 
more occasions following their arrests (the lockup test plus at 
least three subsequent tests)-performed significantly better on 
pretrial release than other released defendants, while those 
21. TOBORG ET AL., supra note 18, at 18. 
22. Douglas A. Smith et a!., Drug Use and Pretrial Misconduct in New York 
City, 5 J. QUANTITATIVE CRIMINOLOGY 101 (1989). 
23. !d. at 122-23; see also Cathryn Jo Rosen & John S. Goldkamp, The Consti-
tutionality of Drug Testing at the Bail Stage, 80 J. CRIM. L. & CRIMINOLOGY 114, 
165 (1989). ("Preliminary research provides empirical evidence tending to show a 
connection between positive results in bail stage urine testing and performance on 
pretrial release.") (footnote omitted). However, in Smith et al., supra note 22, at 
121-22, the same authors question the empirical support of the general relationship 
between drug use and crimes committed by individuals on pretrial release. 
24. Smith et al., supra note 22, at 124; TOBORG ET AL., supra note 18, at 10. 
25. Christy A. Visher & Richard L. Linster, A Survival Model of Pretrial 
Failure, 6 J. QUANTITATIVE CRIMINOLOGY 153 (1990); Christy A. Visher, Incorporat-
ing Drug Treatment in Criminal Sanctions, N.I.J. REP., Summer 1990, at 2 n.2. 
However, the author notes that in two other jurisdictions (Miami and Tucson), 
drug test results did not appear strongly related to rearrest or failure-to-appear 
rates, an inconsistency which she suggests may be explained by differences in 
study design and analysis and also by different patterns of drug use. !d. at 2-3, 7 
n.3. 
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who did not comply with pretrial testing orders did notably 
worse.26 Indeed, both the rates of pretrial rearrest and failure 
to appear for defendants who participated in the 
program-about two-thirds of all persons ordered into the 
programs-were about one-half the rates of the defendants who 
did not participate.27 Thus, not only can initial lockup urine 
tests help classify defendants for pretrial release risks, but the 
nature of defendants' participation in the pretrial urine testing 
program after release can also help to assess pretrial release 
risks after enrollment in the program. 28 
Judges in the District of Columbia recognize and appreci-
ate the utility of this potential "signaling" effect of drug testing 
for pretrial monitoring purposes. When asked about the effects 
of the testing program on rates of failure to appear and pretrial 
rearrest, most judges thought both rates were lower than they 
would be without the program and that a defendant's perfor-
mance in the program (both in terms of test results and test 
participation) served as a good "signal" or indicator with re-
spect to both risks, particularly with respect to failures to ap-
pear.29 
Ill. PRETRIAL DRUG TESTING AND THE CONSTITUTIOW0 
Despite the obvious benefits that can be derived from pre-
trial drug testing, legal opposition to the procedure still exists. 
26. TOBORG ET AL., supra note 18, at 18. 
27. TOBERG ET AL., supra note 18, at 18. 
28. TOBORG ET AL., supra note 18, at 18. 
29. TOBORG ET AL., surpa note 18, at 13; see also MARY A. TOBORG & JOHN P. 
BELLASSAI, U.S. DEP'T OF JUSTICE, PRETRIAL URINE TESTING IN THE DISTRICT OF 
COLUMBIA: THE PERSPECTIVES OF JUDICIAL OFFICERS IN 1989 28-29 (1989) 
(available from the National Criminal Justice Reference Service, Rockville, Mary-
land); MARY A. TOBORG ET AL., ASSESSMENT OF PRETRIAL URINE TESTING IN THE 
DISTRICT OF COLUMBIA: PERIODIC URINE TESTING AS A SIGNALING DEVICE FOR PRE-
TRIAL RELEASE (MONOGRAPH 5) (1989) [herinafter PRETRIAL RELEASE]. 
30. In part V, infra, we also recognize the utility of post-conviction drug 
testing-where fewer constitutional protections exist-including a diminished ex-
pectation of privacy, than in the pretrial setting. See, e.g., United States v. Wil-
liams, 787 F.2d 1182, 1185 (7th Cir. 1986); Storms v. Coughlin, 600 F. Supp. 1214, 
1221 (S.D.N.Y. 1984); see also Griffin v. Wisconsin, 483 U.S. 868, 874 (1987); Bell 
v. Wolfish, 441 U.S. 520 (1979); Campbell v. McGruder, 580 F.2d 521 (D.C. Cir. 
1978); WAYNE R. LAFAVE, 4 SEARCH AND SEIZURE-A TREATISE ON THE FOURTH 
AMENDMENT §§10.9-10.10 (2d ed. 1987). But see Cathryn Jo Rosen, The Fourth 
Amendment Implications of Urine Testing for Evidence of Drug Use in Probation, 
55 BROOK. L. REV. 1159, 1182 n.97, 1213-15, 1226-28, 1239 (1990). The weight of 
authority supports the Administration's view that post-conviction drug testing is 
both a legally accepted and an effective component of the criminal justice system. 
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The legal arguments advanced in opposition to pretrial testing 
are numerous.31 They include: (1) that pretrial drug testing 
amounts to a substantive due process violation because it plac-
es an unreasonable condition of release on arrestees; (2) that 
the testing procedures are not sufficiently reliable to meet the 
constitutional requirements of procedural due process; (3) that 
pretrial drug testing constitutes a violation of the Fourth 
Amendment proscription against unreasonable searches and 
seizures; (4) that pretrial drug testing violates the constitution-
al privilege against self incrimination guaranteed by the Fifth 
Amendment; and (5) that the procedure deprives arrestees of 
their Sixth Amendment right to counsel.32 However, none of 
these arguments is sufficiently compelling to render pretrial 
testing unconstitutional. 33 
A. The Substantive Due Process Argument 
In Bell v. Wolfish,34 the Supreme Court held that the 
Fifth Amendment's Due Process Clause (made applicable to the 
States by the Fourteenth Amendment) protects arrestees from 
being punished prior to an adjudication of guilt. 35 Thus, in 
viewing the constitutionality of conditions of pretrial release, 
the appropriate inquiry centers on whether the conditions of 
release amount to punishment of the arrestee.36 Specifically, 
the Supreme Court held "that in determining whether a gov-
ernmental action is considered punishment in the constitution-
al sense of the word a court must decide whether the disability 
is imposed for the purpose of punishment or whether it is but 
an incident of some other legitimate governmental purpose."37 
Previously, the Supreme Court had held that the substantive 
31. See generally Rosen & Goldkamp, supra note 23, at 114. 
32. A District of Columbia study in which twenty-five judges and commissioners 
were interviewed showed that pretrial drug testing actually enhanced Eighth 
Amendment bail rights. This salutary result occurs because drug testing affords 
arrestees who are drug users the option of being placed on pretrial release without 
posting a monetary bond, provided that they submit to continued urine test moni-
toring following their release. See Abell, supra note 10, at 956 (citing TOBORG & 
BEUASSAI, supra note 29, at 17). 
33. See EvANS, supra note 20, at 17; Abell, supra note 10, at 945-946; Charles 
J. Cooper, The Constitutionality of Drug Testing, 35 FED. BAR NEWS J. 359 (1988); 
Stewart, supra note 14, at 74-75. 
34. 441 U.S. 520 (1979). 
35. ld. at 535. 
36. ld. 
37. ld. at 538. 
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due process analysis requires courts to assess "whether there is 
an alternative purpose to which [the condition of release] may 
rationally be connected, and whether the procedure under re-
view appears excessive in relation to the alternative pur-
pose."38 So long as a particular "condition or restriction" is 
reasonably related to a legitimate government objective, the 
Supreme Court has held that it does not, without more, 
amount to "punishment."39 On the other hand, if the restric-
tion or condition is not "reasonably related to a legitimate 
goal-if it is arbitrary or purposeless-a court permissibly may 
infer that the purpose of the governmental action is pun-
ishment."40 
Consistent with the holding in Bell, the Federal Bail Re-
form Act of 1984 (Act)41 has been held to authorize courts to 
detain arrestees charged with certain serious felonies if the 
government demonstrates by "clear and convincing evidence" 
after an adversary hearing, that no release conditions "will 
reasonably assure the safety of any other person and the com-
munity."42 While the Act grants courts the authority to detain 
arrestees prior to trial, it also gives them the authority to place 
conditions and restrictions on arrestees who are released.43 
Accordingly, the Supreme Court has held that "pretrial release 
may be accompanied by burdensome conditions that effect a 
significant restraint on liberty."44 
As discussed in Part II, supra, there is a direct correlation 
between drug use and the increased likelihood that defendants 
will fail to appear for future court proceedings, be rearrested, 
or both. The substantive due process test articulated in Bell is 
satisfied by this nexus.45 
38. Kennedy v. Mendoza-Martinez, 372 U.S. 144, 168-69 (1963). 
39. Bell, 441 U.S. at 539. 
40. ld. 
41. 18 U.S.C. §§ 3141 -3156 (Supp. III 1982). The Act states that: "The judi-
cial officers shall hold a hearing to determine whether any conditions or combina-
tion of conditions set forth in subsection (c) of this section will reasonably assure 
the appearance of such person as required and the safety of any other person and 
the community." !d. § 3142 (f). 
42. United States v. Salerno, 481 U.S. 739, 741 (1987). 
43. ld. at 742. The Supreme Court in United States v. Salerno held that when 
determining bail and pretrial release conditions courts must consider the following 
statutorily enumerated factors: (1) a defendant's criminal charge, (2) a defendant's 
prior record of conviction, (3) a defendant's community ties, and (4) a defendant's 
history of drug abuse. ld. at 742-43. 
44. Gerstein v. Pugh, 420 U.S. 103, 114 (1975). 
45. 441 U.S. at 539. 
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While alternatives to systematic urine testing to detect 
drug use could theoretically be employed, whether at the time 
of the initial appearance or during periods of pretrial or post-
conviction release, the likelihood of discovering such use by 
self-reporting or other measures is not as reliable as with urine 
testing.46 Arrestees are less likely to report their drug use, 
knowing that their initial release may be adversely affected by 
such an admission, or that future testing or participation in a 
treatment program may be imposed as a condition of re-
lease.47 Against this reality, mandatory urine testing cannot 
be considered excessive and is, therefore, not violative of the sub-
stantive due process test as articulated in Kennedy v. Mendoza-
Martinez.48 
B. The Procedural Due Process Argument 
To satisfy the requirements of procedural due process, the 
process used to detect drug use must be sufficiently reliable so 
as to ensure the accuracy of the results.49 In most jurisdic-
tions which have initiated mandatory pretrial drug testing, the 
Enzyme Multiplied Immunoassay Technique (EMIT) system is 
used to test the urine samples. Various courts have concluded 
that the EMIT test is presumptively reliable and that the re-
sults are, therefore, admissible evidence. 50 Thus, once this 
threshold assessment of the reliability of the test is made, 
procedural due process is not offended so long as the proce-
46. See discussion supra part II. 
47. See, e.g., supra, studies cited in note 18 and the report and report findings, 
infra, notes 100 & 102. 
48. 372 U.S. 144, 168-69 (1963). Even if other methods of detecting drug use 
were just as reliable and could be accomplished by less intrusive measures, system-
atic pretrial urine testing could, nevertheless, be deemed reasonable. Although the 
use of available alternative sources of information or evidence must be considered 
when determining the reasonableness of a particular search, courts need not rule 
that a restriction or condition is excessive merely because a less intrusive alterna-
tive exists. Accord Skinner v. Railway Labor Executives' Ass'n, 489 U.S. 602, 629 
n.9 (1989); National Treasury Employees Union v. Von Raab, 816 F.2d 170, 178 
(5th Cir. 1987), affd, 489 U.S. 656 (1989) (citing Colorado v. Bertine, 479 U.S. 367 
(1987)). 
49. National Treasury Employees Union v. Von Raab, 816 F.2d 170, 181 (5th 
Cir. 1987). 
50. See, e.g., Spense v. Farrier, 807 F.2d 753, 756 (8th Cir. 1986); Wykoff v. 
Resig, 613 F. Supp. 1504, 1512 (N.D. Ind. 1985); Jensen v. Lick, 589 F. Supp. 35, 
39 (D.N.D. 1984); Jones v. United States, 548 A.2d 35, 46 (D.C. 1988); Smith v. 
State, 298 S.E.2d 482, 484 (Ga. 1983); see also Abell, supra note 10, at 947 n.19; 
Mike Lawrence & Maria Hewitt, Accuracy and Reliability of Urine Drug Tests, 36 
KAN. L. REV. 641 (1988); Rosen & Goldkamp, supra note 23, at 122 n.42. 
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dures employed to protect the integrity of the urine samples 
are adequate to insure the accuracy and reliability of the re-
sults which are presented to the court.51 
C. The Fourth Amendment Search and Seizure Argument 
The Fourth Amendment of the United States Constitution 
guarantees, "[t]he right of the people to be secure in their per-
sons, houses, papers and effects, against unreasonable searches 
and seizures."52 This amendment protects persons, "against 
certain arbitrary and invasive acts by officers of the govern-
ment or those acting at their direction."53 The Supreme Court 
has ruled that the collection and testing of urine samples is a 
"search" under the Fourth Amendment. 54 In reaching this con-
clusion, the Court has stated that "[t]here are few activities in 
our society more personal or private than the passing of 
urine."55 In addition, the Supreme Court noted that the test-
ing of urine samples can reveal other medical information 
which may implicate privacy interests.56 
However, pretrial urine testing only transgresses the 
Fourth Amendment if the taking of the samples for testing 
purposes is unreasonable. 57 When determining reasonable-
ness, the Supreme Court has stated that in each case it re-
quires a balancing of "the intrusion [of a particular practice] on 
the individual's Fourth Amendment interests against its pro-
motion of legitimate governmental interests."58 Courts must 
consider various factors when conducting this balancing test, 
including: (1) the scope of the particular intrusion; (2) the man-
51. Von Raab, 816 F.2d at 182. 
52. U.S. CONST. amend. IV. 
53. Skinner v. Railway Labor Executives' Ass'n, 489 U.S. 602, 613-14 (1989), 
(citing Camara v. Municipal Court, 387 U.S. 523, 528 (1967)). 
54. Skinner, 489 U.S. at 617 ("Taking a blood or urine sample might also be 
characterized as a Fourth Amendment seizure, since it may be viewed as a mean-
ingful interference with the [individual's] possessory interest in his bodily fluids."). 
!d. at 617-18 n.4. However, once an act is characterized as a "search," it becomes 
unnecessary for Fourth Amendment purposes to also determine whether a seizure 
occurred. !d.; see also National Treasury Employees Union v. Von Raab, 489 U.S. 
656 (1989). 
55. Skinner, 489 U.S. at 617 (quoting Von Raab, 816 F.2d at 175). 
56. !d. 
57. !d. at 619 ("[T]he Fourth Amendment does not proscribe all searches and 
seizures, but only those that are unreasonable."); see United States v. Sharpe, 470 
U.S. 675, 682 (1985)); Schmerber v. California, 384 U.S. 757, 768 (1966) . 
58. Skinner, 489 U.S. at 619 (citing Delaware v. Prouse, 440 U.S. 648, 654 
(1979)); United States v. Martinez-Fuerte, 428 U.S. 543 (1976). 
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ner in which it is conducted; (3) the justification for initiating 
it; and (4) the place in which it is conducted.59 
In criminal cases, searches or seizures will generally be 
held reasonable only when "accomplished pursuant to a judicial 
warrant issued upon [a showing of] probable cause."60 There 
are many exceptions to the warrant requirement, however.61 
Pretrial drug testing has all of the ingredients of the non-crimi-
nal or administrative exception. The Supreme Court has deter-
mined that such searches are reasonable in the absence of 
probable cause or some quantum of individualized suspicion 
"where a Fourth Amendment intrusion serves special govern-
mental needs beyond the normal need for law enforcement,"62 
and when balanced against the individual's privacy expecta-
tions it would be "impractical to require a warrant or some 
level of individualized suspicion in the particular context."63 
The results of pretrial urine tests are only used for admin-
istrative and regulatory purposes, although admittedly within 
the criminal justice setting.64 Moreover, pretrial urine tests 
are only conducted on those arrestees who consent to them. 
While as a practical matter the refusal to provide an initial 
sample may adversely impact an arrestee's pretrial release 
status, the arrestee nevertheless retains the right of refusal. 65 
Similarly, arrestees who are released subject to a condition of 
59. Bell v. Wolfish, 441 U.S. 520, 559 (1978). 
60. Skinner, 489 U.S. at 619 (citing Payton v. New York, 445 U.S. 573, 586 
(1980)); Mincey v. Arizona, 437 U.S. 385, 390 (1978). 
61. National Treasury Employees Union v. Von Raab, 489 U.S. 665 (1989) 
("While we have often emphasized, and reiterate today, that a search must be 
supported, as a general matter, by a warrant issued upon probable cause, our 
decision in Railway Labor Executives reaffirms the longstanding principle that nei-
ther a warrant nor probable cause, nor, indeed, any measure of individualized sus-
picion, is an indispensable component of reasonableness in every circumstance.") 
(citations omitted). 
62. ld. 
63. ld. at 665-66; see also Skinner, 489 U.S. at 619 ("When faced with such 
special needs, we have not hesitated to balance the governmental and privacy 
interests to assess the practicality of the warrant and probable cause requirements 
in the particular context.") (citations omitted); Willner v. Thornburgh, 928 F.2d 
1185, 1187 (D.C. Cir.), cert. denied, 112 S. Ct. 669 (1991). 
64. Rosen, supra note 30, at 1191 ("[A]dministrative searches may be conducted 
with the primary purpose of discovering criminal misconduct in order to impose 
non-criminal sanctions involving loss of important rights and privileges or interests, 
such as continued employment, the right to attend school, or imposition of civil 
fines and penalties."); see also Griffin, 483 U.S. at 873-74. 
65. JOHN A. CARVER, U.S. DEP'T OF JUSTICE, DRUGS AND CRIME: CONTROLUNG 
USE AND REDUCING RISK THROUGH TESTING (1986). 
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regular pretrial drug testing expressly consent to abide by this 
condition, along with any other conditions imposed by the 
court.66 
Furthermore, the results of pretrial urine testing cannot be 
used in determining guilt on the underlying offense.67 For ex-
ample, in the District of Columbia, urine-test results are not 
admissible on the issue of guilt on the underlying charge, al-
though they can be used for other specified collateral purposes, 
including use at perjury trials and contempt proceedings 
brought against arrestees for violating conditions of release, 
and for purposes of impeachment in any subsequent proceed-
ing.ss 
The government's legitimate interests in ensuring that 
arrestees who are placed on pretrial release return to court as 
instructed and do not commit new offenses while on release is 
significantly advanced by pretrial drug testing.69 The nexus 
between the furtherance of these legitimate interests and man-
datory drug testing is founded in the growing body of empirical 
evidence showing a positive correlation between drug use and 
crime and between drug use and failure to appear for subse-
quent court appearances. 70 
On the other hand, whatever additional intrusion on the 
privacy interests of arrestees is occasioned by pretrial drug 
testing is minimal.71 The persons being tested are already in 
66. ld. 
67. ld. 
68. D.C. CODE ANN. § 23-1303(d) (1981 & Supp. 1988); see also infra notes 88-
89; TOBORG ET AL., supra note 18, at 2. 
69. See, e.g., discussion supra part II. 
70. See supra part II. In addition, drug use is itself a crime, and procedures 
like pretrial drug testing, which detect illegal drug use and discourage further 
illegal use, help reduce the incidence of this crime. Thus, "[e]ven if no empirical 
data existed that correlated drug testing and decreased criminal activity, drug 
testing at least has the demonstrable result of lowering future drug use, a goal 
which the government has a legitimate interest in advancing." Abell, supra note 
10, at 951 (footnote omitted). 
71. Abell, supra, note 10, at 954; see also Stewart, supra note 14, at 75 ("What 
is reasonable also requires 'balanc[ing] the nature and quality of the intrusion on 
the individual's Fourth Amendment interests against the importance of the govern-
mental interests alleged to justify the intrusion.' Use of urine is considered far less 
intrusive than the drawing of blood, which requires an invasive technique.") (ci-
tation omitted). But see Skinner v. Railway Labor Executives' Ass'n, 489 U.S. 613, 
626-28 (1989) (recognizing a privacy interest of constitutional dimensions in urine 
testing, even though it does not involve an invasive act, but one which was never-
theless diminished and outweighed by the government's public safety interests); see 
also Willner v. Thornburgh, 928 F.2d 1185, 1187 (D.C. Cir.), cert. denied, 112 S. 
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custody, and this alone constitutes a substantial restriction on 
the liberty rights of the arrestees. 72 Furthermore, a person 
detained pursuant to a lawful arrest has already been seized 
and can thereafter be compelled to give handwriting and blood 
samples, voice exemplars, and to stand in line-ups.73 
Requiring the government either to obtain a warrant or to 
develop individualized suspicion as predicates for pretrial urine 
testing would severely hinder the government's ability to fur-
ther the dual objectives derived from such testing. In order to 
have test results available for arrestees' initial court appear-
ances, when the issue of bail must be addressed-which occurs 
within hours after an arrest-the tests must be conducted 
expeditiously. The Supreme Court has recognized that the 
government's interest in dispensing with the requirement of a 
search warrant is at its strongest when "the burden of obtain-
ing a warrant is likely to frustrate the governmental purpose 
behind the search."74 If the test results are not completed by 
the time of required bail hearings, the government's legitimate 
purposes are not only frustrated, but are totally defeated. Simi-
larly, the systematic and expeditious processing of urine sam-
ples, and the mass screening of arrestees required if the gov-
ernment is not to be confined to relying on inaccurate measures 
of recent drug use (such as self-reporting) in order to further 
the purposes of drug testing, would be compromised if individu-
alized suspicion were to be required before an arrestee could be 
tested. 75 
Ct. 669 (1991). 
72. Bell v. Wolfish, 441 U.S. 520, 537 (1978). 
73. National Treasury Employees Union v. Von Raab, 816 F.2d 170, 181 (5th 
Cir. 1987), affd, 489 U.S. 656 (1989) (quoting United States v. Wade, 388 U.S. 
218, 222 (1967)). 
74. Skinner v. Railway Labor Executives' Ass'n, 489 U.S. 613, 623 (1989) (quot-
ing Camara v. Municipal Court of San Francisco, 387 U.S. 523, 533 (1967)). 
75. One commentator has observed: 
[P]retrial urinalysis specifically avoids "individualized suspicion" analysis 
by requesting all persons in lock-up to participate. Further, the liberty 
and property interests-employment versus the recognized government 
interest in setting bail-are so unrelated that the "individualized suspi-
cion" need not be formed. The results of pretrial urinalysis testing are not 
used to deny or terminate employment. Nor are they used to effect an 
arrest and thus seize a person, thereby limiting liberty. On the contrary, 
arrestees submit to testing voluntarily to provide information related to 
bail. No individual is singled out as a suspect of unlawful behavior or as 
a danger to the community; thus individualized suspicion is never formed. 
Therefore, the intrusion into liberty or property interests need not be 
balanced against individualized "reason to believe" because this analysis 
356 B.Y.U. JOURNAL OF PUBLIC LAW [Volume 5 
In sum, the government's legitimate interests in ensuring 
that arrestees who are released pending trial return to court as 
instructed and refrain from committing new offenses while on 
conditional release are significantly advanced by pretrial urine 
testing. On the other hand, the intrusion on the Fourth 
Amendment rights of arrestees which occurs from the taking of 
the urine samples, prior to an initial appearance or as a condi-
tion of pretrial release, is minimal. Balancing the competing 
interests of the government and arrestees in the context of 
pretrial urine testing tilts the scales heavily in favor of the 
government and justifies the testing of all arrestees without 
first requiring that the government acquire a warrant or make 
a showing of individualized suspicion. 76 
D. The Privilege Against Self-Incrimination Argument 
The Fifth Amendment privilege against self-incrimination 
"only protects an accused from being compelled to testify 
against himself, or otherwise provide the government with 
evidence of a testimonial or communicative nature.'m The in-
formation discovered from a drug test does not reveal any knowl-
edge that the person tested was required to communicate.78 
Moreover, pretrial drug test results are used simply to aid the 
court in selecting appropriate release conditions.79 Therefore, 
simply does not apply. 
Abell, supra note 10, at 955 (citations omitted). But see Rosen & Goldkamp, supra 
note 23, at 171 (Absent consent, implementation of mass urine testing programs 
may be impossible if pre-bail drug testing is limited by requiring reasonable, indi-
vidualized suspicion.). 
76. Skinner, 489 U.S. at 626-28; see also Willner v. Thornburgh, 928 F.2d 1185, 
1191 (D.C. Cir.), cert. denied, 112 S. Ct. 669 (1991). 
77. See United States v. Dionisio, 410 U.S. 1, 7 (1973) (producing voice exem-
plars does not violate the privilege against self-incrimination); Gilbert v. California, 
388 U.S. 263, 266-67 (1967) (requiring handwriting samples does not violate the 
privilege against self-incrimination); United States v. Wade, 388 U.S. 218, 221-23 
(1967) (requiring arrestees to stand in a lineup does not violate the privilege 
against self-incrimination); Schmerber v. California, 384 U.S. 758, 760 (1966) 
(requiring an arrestee to furnish blood samples does not violate the privilege 
against self-incrimination). In the case of pretrial urine testing, as in these cases, 
an arrestee's testimonial capacities are in no way implicated. Indeed, "[an 
arrestee's] participation, except as a donor, [is] irrelevant to the results of the test, 
which depend on chemical analysis and on that alone." Id. at 765 (footnote omit-
ted). 
78. Schmerber, 384 U.S. at 765. 
79. The District of Columbia pretrial drug test results are also routinely used 
by judges when imposing sentences. Since guilt has already been established, there 
is nothing legally impermissible about this practice. See id. at 761 (holding that 
341] NATIONAL DRUG CONTROL STRATEGY 357 
the Fifth Amendment privilege against self-incrimination can-
not be considered a bar to mandatory pretrial urine testing. 
E. The Sixth Amendment Right to Counsel Argument 
The Sixth Amendment guarantees all criminal defendants 
the right to the assistance of counsel. 80 The right attaches at 
the "time adversary judicial proceedings have been initiated 
against [the accused]."81 Such proceedings have been charac-
terized by the Supreme Court as "critical stage[s] of the 
prosecution."82 While the Supreme Court has not yet ruled on 
the specific issue of whether the right to counsel attaches when 
urine samples are collected or when pretrial drug testing is 
conducted, the Court's precedents clearly suggest that neither 
of these events occurs during a "critical stage in the prosecu-
tion." Like the post-arrest taking or testing of blood, finger-
prints, clothing, hair, and the like, the denial of the right to 
have counsel present when the urine samples are taken or 
when the pretrial drug tests are performed does not violate a 
defendant's Sixth Amendment rights, "since there is minimal 
risk that his counsel's absence at such stages might derogate 
from his right to a fair trial."83 However, even if arrestees had 
the right to have their attorneys present, the Sixth Amendment 
would not preclude the government from conducting pretrial 
urine tests. 84 
even when the non-testimonial evidence is used to discover evidence that can be 
used to prosecute the individual, there is no violation of the privilege against self-
incrimination). The test results merely provide additional information for the 
sentencing judge to consider when assessing whether convicted individuals will 
comply with conditions of probation or pose a danger to the public if a proba-
tionary sentence is imposed. See EvANS, supra note 20, at 18. 
80. U.S. CONST. amend. VI. 
81. Kirby v. Illinois, 406 U.S. 682, 688 (1972). 
82. Simmons v. United States, 390 U.S. 377, 382-83 (1967). 
83. United States v. Wade, 388 U.S. 218, 227-28 (1967); see, e.g., Gilbert v. 
California, 388 U.S. 263 (1967) ("The taking of the [handwriting] exemplars was 
not a 'critical' stage of the criminal proceedings .... "); Schmerber v. California, 
384 U.S. 758, 766 (1966) (no right to counsel at the post-arrest drawing of a blood 
sample because "[n]o issue of counsel's ability to assist [the defendant] in respect 
of any rights he did possess is presented."); see also 3 JOSEPH G. COOK, CONSTITU-
TIONAL RIGHTS OF THE ACCUSED § 7:3 (2d ed. 1986 & Supp. 1989). 
84. See, e.g., Wade, 388 U.S. at 237-38. 
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IV. EXISTING PROGRAMS FOR DRUG TESTING OF ARRESTEES 
A. The Washington, D.C., Program85 
Beginning in 1984, a comprehensive pretrial drug testing 
program for adult defendants was implemented in the District 
of Columbia, funded by the National Institute of Justice (NIJ). 
When Federal funding for the program expired in 1986, the 
program was maintained through local funding. The testing 
program is operated by the District of Columbia Pretrial Ser-
vices Agency (PSA), an independent agency of the District of 
Columbia Government. The PSA is charged by law with the 
responsibility for (1) interviewing all adult arrestees to deter-
mine their eligibility for pretrial release; (2) making recommen-
dations as to appropriate terms and conditions for release in all 
criminal cases; and (3) monitoring compliance with release 
conditions for all defendants, except those released on surety 
bonds.86 
PSA attempts to test all adult arrestees coming through 
the District of Columbia's Superior Court lockup for the pres-
ence of selected drugs in their urine, prior to their initial court 
appearances. The tests will detect the presence of opiates (pri-
marily heroin), cocaine, PCP, amphetamines, and 
methadone.87 The urine samples are collected in the presence 
of a PSA worker.88 The samples are then taken by PSA staff 
85. D.C. CODE ANN. § 23-1303 (1981 & Supp. 1988). While not specifically au-
thorizing drug testing, the statutory basis for the District of Columbia's testing 
program rests in this section and the other sections (23-1301 to 23-1332) of Chap-
ter 13 of Title 23 of the D.C. Code [Pretrial Services Agency and Pretrial De-
tention]. A more complete description of the District of Columbia drug testing 
program can be found in articles by John A. Carver, Esq., Director of the District 
of Columbia Pretrial Services Agency. See John A. Carver, Pretrial Drug Testing: 
An Essential Step in Bail Reform, 5 B.Y.U. J. PuB. L. ??? (1991); CARVER, supra 
note 65. For other evaluations of the District of Columbia program see TOBORG & 
BErLASSAI, supra note 29 and PRETRIAL RELEASE, supra note 29. 
86. TOBORG & BELLASSAI, supra note 29, at 1. 
87. Beginning in 1986, the District of Columbia Pretrial Services Agency (PSA) 
also began testing all juvenile arrestees for the same selected drugs except metha-
done. TOBORG AND BELLASSAI, supra note 29, at 5. 
88. The Supreme Court considered whether urine samples are taken under the 
direct supervision of a monitor as a relevant factor when assessing the degree of 
the intrusion on the individual's privacy rights. Skinner v. Railway Labor 
Executives' Ass'n, 489 U.S. 613, 626 (1989). While the Court stated that the lack 
of such monitoring lessened the extent of the intrusion, it nevertheless recognized 
"the desirability of such a procedure to ensure the integrity of the sample." ld. 
Moreover, the Skinner Court, in the context of employee testing, concluded that the 
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from the court lockup directly to PSA's laboratory-located in 
the same building-for analysis, using the EMIT system.89 
Test results are made available that same day-usually within 
1-2 hours-to PSA's in-court representatives, who are present 
at the arrestee's initial court appearance to make the test re-
sults available to the sitting judge or commissioner and to 
make pretrial release recommendations to the court. 
Before this program began, the only release option specifi-
cally tailored to the needs of drug users had been referrals for 
treatment. With the advent of the drug testing program, how-
ever, a new release alternative became available for drug-using 
defendants, namely, placement in PSA's periodic urine-testing 
program.90 If an individual repeatedly tests positive while on 
pretrial release and the positive results are confirmed by a 
second EMIT test, the defendant may be considered in violation 
of a condition of his release or held in contempt of court for 
failure to comply with a court-ordered condition of release. A 
series of graduated sanctions can then be imposed, ranging 
from more frequent drug testing to additional release 
conditions-including the posting of a money bond-and the 
imposition of a contempt of court citation resulting in a fine or 
a prison sentence. 
nature of the industry was the most important factor to consider when calculating 
the reasonableness of employees' expectations of privacy. ld. at 627. Since the 
industry in Skinner (the railroad industry) "is regulated pervasively to ensure 
safety, a goal depeadent, in substantial part, on the health and fitness of covered 
employees," the Court held that the justifiable expectations of privacy for such 
employees is minimal. ld. at 627-28. 
In the context of pretrial testing, arrestees have been charged with violating a 
criminal statute and are already in custody ,-ihen the urine samples are taken. 
Furthermore, the arrestees do not have access to a private bathroom when the 
samples are collected during their detention. Under these circumstances, arrestees' 
reasonable expectations of privacy-at least as to their urine-cannot be considered 
substantial. And when weighed against the compelling government interest to 
determine whether arrestees are drug users for the purpose of setting bail, the 
government's interests are clearly superior. Accordingly, the presence of the PSA 
monitor is not so intrusive as to make the collection of the urine samples an 
unreasonable search or seizure. 
89. The District of Columbia Court of Appeals has held "that [the Enzyme Mul-
tiplied Immunoassay Technique] EMIT test results are presumptively reliable and 
generally admissible into evidence in every case." Jones v. United States, 548 A.2d 
35, 46 (D.C. 1988) (citation omitted). In Jones, the government was allowed to 
introduce evidence of a positive pre-arraignment urine test to impeach the 
defendant's testimony that he did not know the substance he was charged with 
possessing was cocaine. 
90. Judges also use the information in fashioning appropriate sentences. 
TOBORG & BELLASSAI, supra note 29, at 2; see also supra notes 68 & 79. 
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Though it began as a research program, the PSA drug 
testing program now comprises an integral part of the pretrial 
(as well as the post-conviction) decision-making process in the 
District of Columbia's Superior Court. During the period from 
the program's implementation on March 5, 1984, until January 
1, 1988, some 57,000 criminal defendants in the District of 
Columbia program were tested.91 In 1988 alone, the agency 
conducted 35,000 prisoner interviews, sent out 60,000 court 
appointment letters, and performed more than 50,000 drug 
tests. 92 
B. Other Local Programs 
The Washington, D.C., drug testing program has served as 
a model for a number of other programs around the country.93 
Beginning in 1987, the United States Department of Justice's 
Bureau of Justice Assistance (BJA), seeking to replicate and 
test the "D.C. model" in other jurisdictions, contracted with the 
Pretrial Services Resource Center in Washington, D.C., to as-
sist BJA in selecting from among applicant jurisdictions a lim-
ited number of sites to implement pretrial drug testing pro-
grams, and to provide technical assistance to those sites during 
the period when discretionary Federal funding was provided.94 
Since then, seven such programs have been initiated: Pima 
County, Arizona (Tucson, beginning in 1987); Multnomah 
County, Oregon (Portland, beginning in 1987); New Castle 
91. Stewart, supra note 14, at 73. 
92. David S. Broder, D.C. Pretrial Agency Is a Small but Vital Cog in Wheels 
of Justice, WASH. POST, May 28, 1989, at Cl. 
93. The Office of National Drug Control Policy has emphasized the importance, 
at both the State and Federal levels, of devising workable measures of account-
ability to ensure that limited funds go to those programs that have achieved 
demonstrable results. See, e.g., OFFICE OF NATIONAL DRUG CONTROL PoUCY, UNDER-
STANDING DRUG TREATMENT (WHITE PAPER) 2-3 (1990); STATUS REPORT, supra note 
4, at 1. 
94. PRETRIAL SERVICES RESOURCE CENTER, U.S. DEP'T OF JUSTICE, ESTIMATING 
THE COSTS OF DRUG TESTING FOR A PRETRIAL SERVICES PROGRAM 1 (1989). The 
Resource Center also provides technical assistance to local jurisdictions using 
Federal funds from the Bureau of Justice Assistance's (BJA) block grant program 
to implement pretrial drug testing. The Resource Center has also prepared two 
other monographs, still in draft form and under review by BJA: "Integrating Drug 
Testing into a Pretrial Services System," an implementation guide for program 
administrators, and "Interim Guidelines for Pretrial Drug Testing," which provides 
a framework for initiating and operating a pretrial drug testing program. The 
American Probation and Parole Association is also working with BJA to develop 
guidelines for post-conviction drug testing. 
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County, Delaware (Wilmington, beginning in 1987 and termi-
nated shortly thereafter); Prince George's County, Maryland 
(beginning in 1988); Maricopa County, Arizona (Phoenix, begin-
ning in 1988); Milwaukee County, Wisconsin (beginning in 
1989); and Los Angeles County, California (beginning in 1990 
but involving only pretrial supervision testing). Because of 
funding problems, several jurisdictions have subsequently lim-
ited or discontinued their pre-initial appearance testing pro-
grams.95 
While these are the only federally-funded programs that 
have employed-at least initially-pre-arraignment drug test-
ing on a widespread basis, a number of other state and local 
programs use drug testing on a limited basis at different stages 
of their criminal justice process. A nationwide survey of state 
and local pretrial services programs conducted by the Pretrial 
Services Resource Center in 1990 revealed that 72 of the 180 
programs responding indicated that pretrial drug testing is 
conducted in some capacity. Of these 72 programs, 58 indicated 
that testing is available only as a condition of release and on a 
selective basis.96 
Another survey has recently been conducted by the Nation-
al Criminal Justice Association (NCJA), as part of their study 
to determine the fiscal impact on States of the drug testing 
requirement called for in the National Drug Control Strate-
gy.97 As of January 31, 1991, twenty-four States and the Dis-
95. While not as exhaustive as the studies of the Washington, D.C. program, 
evaluations have been prepared for some of the other demonstration sites. See 
STEFAN KAPSCH & LOUIS SWEENY, U.S. DEP'T OF JUSTICE, MULTNOMAH COUNTY 
DETECTION AND MONITORING OF DRUG-USING ARRESTEES, EVALUATION FINAL RE-
PORT (REVISED) (1990); JOHN S. GoLDKAMP ET AL., U.S. DEP'T OF JUSTICE, THE 
UTILITY OF DRUG TESTING IN THE ASSESSMENT OF DEFENDANT RISK AT THE PRE-
TRIAL RELEASE DECISION, FINAL REPORT (1989); JOHN S. GoLDKAMP ET AL., U.S. 
DEP'T OF JUSTICE, MEASURING THE IMPACT OF DRUG TESTING AT THE PRETRIAL 
RELEASE STAGE: PRETRIAL DRUG TESTING IN MILWAUKEE COUNTY, NEW CASTLE 
COUNTY AND PRINCE GEORGE'S COUNTY: PRELIMINARY REPORT WITH EVALUATION 
UPDATE FROM THE PIMA COUNTY PROGRAM (1989). 
96. Conversation with the Pretrial Services Resource Center, Washington, D.C., 
February 1991. 
97. The National Criminal Justice Association (NCJA) is a special interest 
group based in Washington, D.C., that represents States on crime control and 
public safety matters and provides staff support to the National Governors 
Association's Committee on Justice and Public Safety. The impact study provision 
was incorporated into the State-Justice appropriations bill, H.R. 2991, lOlst Cong., 
1st Sess. (1989), which was signed into law by President Bush on November 21, 
1989. The study is expected to be completed by the end of 1991. The study is 
being funded by the National Institute of Justice. 
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trict of Columbia had responded to the survey. Preliminary 
results suggest that drug testing programs for probationers and 
parolees are most common, with at least some testing of those 
populations in twenty-three of the twenty-five jurisdictions; in 
addition, seventeen states reported testing individuals who 
were under some other form of conditional release (either pre-
trial or post-conviction, or both). Nineteen states also reported 
testing individuals who were incarcerated, and fifteen reported 
testing inmates in other correctional facilities, such as "boot 
camps." Thirteen states reported testing arrestees, and ten 
states reported testing arrestees who had been detained follow-
ing their initial court appearance; however, early analyses 
suggest that much of the reported testing of these populations 
occurs as part of the nationwide Drug Use Forecasting (DUF) 
program and not as a sanction or as a monitoring measure. A 
number of states reported having existing testing authority but 
no testing programs; most often this authority covers probation 
and parole populations, followed by the testing of individuals 
on other forms of conditional release (either pretrial or post-
conviction), prison inmates, and persons in other types of cor-
rectional facilities. 98 
C. Drug Testing Programs in the Federal Courts 
Section 7304 of the Anti-Drug Abuse Act of 1988,99 re-
quired the Director of the Administrative Office of the United 
States Courts ("Administrative Office") to establish a demon-
stration program of mandatory drug testing of criminal defen-
dants in eight Federal judicial districts. The program began 
January 1, 1989, and concluded two years later, in the follow-
ing districts: the Middle District of Florida; the Southern Dis-
trict of New York; the Eastern District of Michigan; the West-
ern District of Texas; the District of Nevada; the District of 
Minnesota; the District of North Dakota; and the Eastern Dis-
trict of Arkansas. As of March 1991, all of the demonstration 
sites were continuing the pretrial testing programs with fund-
ing from the Administrative Office, but only Arkansas was con-
tinuing to test post-conviction releasees on a comprehensive 
basis. 100 To the extent feasible, testing was to be completed 
98. NATIONAL CRIMINAL JUSI'ICE ASSOCIATION, STATUS OF NCJA RESEARCH ON 
!S:'l'UES AFFECTING DRUG TESTING OF CRIMINAL JUSTICE POPULATIONS IN THE 
STATES (DRAFT REPORT) 3-5 (1991). 
99. Pub. L. No. 100-690, 102 Stat. 4181 (codified at 21 U.S.C. § 1501 (1988)). 
100. Conversation with the Administrative Office of the United States Courts, 
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prior to the defendant's initial appearance before a judge or 
magistrate, and the results of the test were to be included in 
the bail report presented to the judicial officer. If the court 
ordered the release of the defendant before trial, under title 18, 
Section 3142(c) of the United States Code, it was to order fur-
ther periodic testing as a condition of release. 101 
The legislation which established the demonstration pro-
gram further provided that for felony offenses occurring or 
completed on or after January 1, 1989, it was to be an addi-
tional, mandatory condition of probation or unsupervised re-
lease that defendants refrain from the illegal use of any con-
trolled substances and submit to periodic urinalysis to detect 
drug use at least once every sixty days. However, the testing 
requirement could be suspended if all of a defendant's drug 
tests were negative after at least one year of testing. 102 
The findings of the demonstration program support other 
studies showing that urine testing is substantially more reli-
able than self-reporting in identifying recent drug users. 103 
Moreover, during the length of the program, there were no 
formal legal challenges to the constitutionality of pretrial drug 
testing in the federal system. 104 In its final report to Con-
gress on the demonstration project, the Administrative Office 
recommended the expansion of pretrial urine testing, both to 
enhance the ability of judicial officers to assess the dangerous-
ness of defendants for bail-setting purposes and to enhance the 
current methods of post-conviction drug testing administered in 
the federal court system. 105 
V. USING DRUG TEST RESULTS TO INCREASE THE EFFECTIVE-
NESS AND FAIRNESS OF THE CRIMINAL JUSTICE SYSTEM 
The results of urine-testing programs can be used at vari-
Washington, D.C., March 1991. 
101. ADMINISI'RATIVE OFFICE OF THE UNITED STATES COURTS, FINAL REPORT ON 
THE DEMONSTRATION PROGRAM OF MANDATORY DRUG TESI'ING OF CRIMINAL DEFEN-
DANTS (1991) [hereinafter MANDATORY DRUG TESTING]. 
102. ld. 
103. !d. at iii. "Pretrial testing prior to the initial appearance identifies 31% of 
all tested defendants in the eight pilot districts as drug users. This compares with 
24% of defendants nationally who admit to a substance abuse problem or a recent 
history of substance abuse during the pretrial services interview." ld.; see also 
supra notes 18 & 47. 
104. MANDATORY DRUG TESTING, supra. note 101, at iii, 18. 
105. MANDATORY DRUG TESTING, supra note 101, at iii-iv, 78. 
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ous stages of the criminal justice process to promote both fair-
ness and effectiveness. 
A. Pretrial Monitoring 
One recent study concluded there are at least four reasons 
to drug test in the criminal justice system: (1) to detect those 
who have recently used drugs; (2) to identify chronic users; (3) 
to monitor and deter drug use among those under the authority 
of the criminal justice system; and ( 4) to estimate national and 
local drug-use trends among criminal justice system popula-
tions.106 Testing immediately after arrest, coupled with regu-
lar drug testing of those who test positive and are then condi-
tionally released, can further each of these purposes. For exam-
ple, the District of Columbia's program, and those patterned 
after it, use arrestees' initial urinalysis results to aid judges in 
determining conditions of pretrial release, and the results of 
those defendants who are periodically tested as a condition of 
pretrial release are used to monitor compliance with release 
conditions imposed by the court. 107 
For pre-trial testing programs to have a meaningful deter-
rent value, however, it is essential that they be able to respond 
quickly when conditions of release are violated.108 This re-
sponsiveness has been part of the program design in the Dis-
trict of Columbia since its inception. 109 However, many judges 
who reported in 1985 that they often held bail revocation and 
contempt hearings for condition of release violations told the 
District of Columbia study team in 1989 that they no longer 
did so as frequently, because of the pressure of growing court 
106. Wish & Gropper, supra note 17, at 324. See also Rosen, supra note 30, at 
1245-46 (identifying three ways to utilize urinalysis in probation-as an assessment 
tool, as a surveillance and monitoring mechanism, and as a deterrent device). 
107. The District of Columbia has also used its drug-test information to assess 
drug-use trends and to develop therefrom appropriate planning and prevention 
strategies. For exam~le, the juvenile urine-testing program resulted from the ongo-
ing adult lockup test results, which disclosed high rates of drug use among young 
adults. These findings created an incentive for earlier interventions, particularly 
before juveniles entered the adult criminal justice system. In addition, because the 
results of the lockup testing of adult arrestees showed surprisingly high rates of 
cocaine and PCP use, a greater percentage of treatment and prevention resources 
were directed to abusers of those drugs. TOBORG ET AL., supra note 18, at 5. 
108. BUREAU OF JUSTICE ASSISTANCE, URINALYSIS AS PART OF A TREATMENT AL-
TERNATIVES TO STREET CRIME (TASC) PROGRAM (MONOGRAPH) 4 (1988). 
109. CARVER, supra note 65 ("If the program is to have the intended deterrent 
effect, defendants must know that violations will be detected and punishment will 
follow."). 
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dockets. Judges in the Portland program have shown a similar 
reluctance to hold show cause hearings. 110 Notwithstanding 
the demands such oversight places on judges, it is important 
that some type of sanction be applied at the earliest indication 
of noncompliance. Such a policy is consistent with research 
findings that even failing to appear for the first post-release 
urine test is a significant indicator of subsequent pretrial mis-
conduct, for either rearrest or failure to appear.lll These 
sanctions, at least initially, need not result in the revocation of 
defendants' release status. There should, however, be a gradu-
ated system of sanctions available, and the sanctions which are 
imposed should be measured to fit the circumstances of the vio-
lation and the offender. 112 
The benefits of pretrial urinalysis programs extend beyond 
the criminal justice arena to the general community and to the 
drug-abusing offenders themselves. 113 Such programs provide 
the government and the public with a fast and reliable tool for 
detecting and deterring recurring drug use-and the criminal 
activity that often accompanies such use-for those on pretrial 
release. They help judges by giving them information about de-
fendants that is of great value in making reasoned and objec-
tive decisions. And, they also help the defendants required to 
participate in the testing programs. For example, such pro-
grams allow for more flexible bail-setting at the pretrial stage. 
Moreover, they help identify those defendants who need drug 
treatment, can coerce them into treatment, and thereafter give 
them a continuing incentive to stay in treatment. 114 At the 
same time, pretrial testing programs enhance the public safety 
by reducing the number of drug-using defendants on pretrial 
110. TOBOIW & BELLASSAI, supra note 29, at 19; KAPSCH, & SWEENY, supra note 
95, at 6.16. 
111. Visher, supra note 14, at 325, 330. 
112. !d. Compare NORVAL MORRIS & MICHAEL TONRY, BETWEEN PRISON AND 
PROBATION: INTERMEDIATE PUNISHMENTS IN A RATIONAL SENTENCING SYSTEM 8 
(1990), wherein the authors argue persuasively for "an enriched range of pun-
ishments better suited to the diversity of crime and criminals to be sentenced, and 
with intermediate punishments being more extensively imposed and more deter-
minedly enforced for the better protection of the community and the larger achieve-
ment of justice." 
113. While this article confines itself to urine testing, a recent comparison of 
different drug testing methods (including different methods of urine testing and 
hair testing) and their applications in criminal justice systems, as well as a discus-
sion of some of the legal and ethical issues raised by the tests, can be found in 
Wish & Gropper, supra note 17. 
114. See Abell, supra note 10, at 956. 
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release. 
B. Monitoring for Treatment Purposes 
The majority of drug users do not need drug treatment, but 
they often do need the threat of social, legal or employer sanc-
tions to motivate them to stop on their own. 115 For these per-
sons, pretrial urine-testing alone, without referral to treatment, 
is often sufficient to prompt them to stop using drugs. 116 Sim-
ilarly, for drug users who need treatment, it is frequently trou-
ble with the law that forces them into treatment. In fact, ac-
cording to the 1989 Treatment Outcome Prospective Study 
(TOPS) done at the Research Triangle Institute, as many as 
one out of two people who enter public drug treatment pro-
grams were under either direct or indirect legal pressure to do 
so.117 
At present, there remains a shortage of public drug treat-
ment slots in this country. Urine test results can help make the 
criminal justice system more effective by allocating those slots 
to the individuals who need them most. Urine-testing programs 
at the bail-fixing stage can also lead to earlier and more ex-
tended interventions. Moreover, different forms of drug abuse 
require different treatment modalities, and urine-testing pro-
grams can help match those individuals who need treatment 
with the most appropriate program. Continued drug-testing as 
a condition of release can help to keep a drug abuser in 
treatment for a longer time, and virtually all studies agree that 
the longer an addict receives treatment, the better his or her 
chances are for long-term success. 118 Nor are the prospects for 
success diminished by the threat of legal sanctions. Indeed, re-
search has determined that those under legal pressure to un-
dergo treatment do as well as, or better, than those who seek 
treatment on their own. 119 
115. See UNDERSTANDING DRUG TREATMENT, supra note 93, at 4. 
116. In the District of Columbia's urine-testing program, PSA 
studies show that while 43 percent of the tests ordered for those on pre-
trial release in 1988 came up positive for at least one of the five drugs, 
more than 700 people who were drig users when first arrested went 
through the entire series of court-ordered post-arrest tests without another 
positive drug finding. 
Broder, supra note 92, at C4. 
117. See UNDERSTANDING DRUG TREATMENT, supra note 93, at 10. 
118. UNDERSTANDING DRUG TREATMENT, supra note 93, at 11, 25. 
119. UNDERSTANDING DRUG TREATMENT, supra note 93, at 11, 25; see also HARRY 
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C. Post-Conviction Monitoring 
While drug testing is of vital importance at the pretrial 
stage to assess risks associated with release pending final adju-
dication of criminal cases, it is of equal importance to the effec-
tive functioning of probation and parole programs. In fact, if 
post-conviction release immediately follows a period of pretrial 
testing during which the arrestee abstained from drug use, or 
the post-conviction release occurs within a relatively short time 
thereafter, the likelihood of successful post-conviction release is 
enhanced. As stated in the initial National Drug Control 
Strategy: 
Probation, like parole, court-supervised treatment, and some 
release programs, should be tied to a regular and rigorous 
program of drug testing in order to coerce offenders to abstain 
from drugs while integrating them back into the community. 
Such programs make prison space available for those drug 
offenders we cannot safely return to the streets. But unless 
they rigidly enforce drug abstinence under the threat of incar-
ceration, these efforts lose their teeth. Drug tests should be a 
part of every stage of the criminal justice process-at the time 
of arrest and throughout the period of probation or incarcera-
tion, and parole-because they are the most effective way of 
keeping offenders off drugs both in and out of detention. 120 
For those defendants who initially test positive for drug 
use, but thereafter cease their use and are then sentenced to 
probation, it is important that they continue on a urine testing 
program as a condition of their probation (or parole). A 1986 
study for the Administrative Office of the United States Courts 
indicated that in the absence of such testing, even probation 
officers in intensive supervision programs cannot identify 
which of their probationers are currently abusing drugs. 121 
There is some evidence that post-conviction urine testing 
K. WEXLER ET AL., U.S. DEP'T OF JUSTICE, A CRIMINAL JUSTICE SYSfEM STRATEGY 
FOR TREATING COCAINE-HEROIN ABUSING OFFENDERS IN CUSTODY 5-6 (1988); 
James Q. Wilson, supra note 14, at 537; Dean R. Gerstein, & Henrick J. Harwood, 
Treating Drug Problems, 1 INsr. OF MED. 9-11 (1990). 
120. NATIONAL DRUG CONTROL STRATEGY I, supra note 5, at 26. 
121. ERIC D. WISH ET AL., U.S. DEP'T OF JUSTICE, IDENTIFYING DRUG USERS AND 
MONITORING THEM DURING CONDITIONAL RELEASE 6 (1988) (citing ERIC D. WISH ET 
AL., ADMINISTRATIVE OFFICE OF THE U.S. COURTS, EsriMATES OF DRUG USE IN 
INTENSIVE SUPERVISION OF PROBATIONERS: RESULTS OF A PILOT STUDY, FEDERAL 
PROBATION (1986)). 
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programs, along with increasing the effectiveness of probation 
and parole, can also reduce recidivism rates. For example, an 
analysis of the California Civil Addict Program found that 
heroin-using parolees who were urine-tested as part of their 
supervision had lower rates of criminality than otherwise simi-
lar parolees who received no supervision or supervision without 
testing. 122 On the other hand, a National Institute of Justice 
study shows that among serious drug users who were also 
involved in criminal activity, those under post-conviction super-
vision without urine testing and those under no legal supervi-
sion at all commit crimes and use drugs at about the same 
rate. 123 Thus, empirical research supports the notion that 
urine testing is an essential component of post-conviction su-
pervision for individuals at high-risk for continued drug use. 
VI. CONCLUSION 
The magnitude of the problems created by drug use is 
staggering. Many of our nation's children are being born physi-
cally and mentally impaired because their mothers used drugs 
during pregnancy. Intolerable numbers of children are being 
abandoned, and in other ways abused and neglected, by their 
drug abusing parents. The streets of many of our cities and 
even our smaller towns are flowing with blood, at least in part 
because of drug involvement by the American citizenry. As a 
result, many of our fellow citizens live in a constant state of 
fear in their neighborhoods. 
Our criminal justice system and our society as a whole 
need as many weapons as can reasonably be deployed if, as a 
Nation, we are to prevail in the war against drugs. Each of the 
National Drug Control Strategies has addressed the many 
challenges we face and has identified the necessary steps we 
must take to meet those challenges. One step that has been 
encouraged in each Strategy has been the use of drug testing 
through urinalysis at all stages of the criminal justice process, 
including the pretrial stage. Such testing is constitutionally 
sound and satisfies traditional notions of bail and pretrial re-
122. ld. at 16. 
123. Christy A. Visher, Incorporating Drug Treatment in Criminal Sanctions, 
N.I.J. REP., Summer 1990, at 3 (citing M.D. ANGLIN ~"'' AL., U.S. DEP'T OF JUSTICE, 
REEXAMINING THE EFFECTS OF PROBATION AND PAROLE ON NARCOTICS ADDICTION 
AND PROPERTY CRIME (FINAL REPORT) (1989)). NIJ is now considering field experi-
ments to evaluate the effect of urine testing of those on probation and parole. ld. 
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lease. At the pretrial stage, testing serves the interest of the 
public by quickly detecting drug use, which is often related 
both to criminal activity and failure to appear for scheduled 
court appearances. It serves the interest of the judiciary by 
giving judges more objective data on which to base their bail 
and pretrial supervision decisions. And, it benefits arrestees by 
providing an additional bail option and pretrial monitoring 
mechanism, and also by coercing many of them to get drug 
treatment and to stay in treatment for an extended period, 
thus improving their chances for long-term success. 
As we continue the battle against illegal drugs, pretrial 
drug testing (and indeed drug testing throughout the entire 
criminal justice system), constitutes an important weapon. It 
will, therefore, continue to be an essential component of the 
Bush Administration's National Drug Control Strategy. 
